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Vaginal microbiota diversity 
and paucity of Lactobacillus species 
are associated with persistent 
hrHPV infection in HIV negative 
but not in HIV positive women
Eileen O. Dareng1,2, Bing Ma3, Sally N. Adebamowo4,5, Ayotunde Famooto2, Jacques Ravel3, 
Paul P. Pharoah1 & Clement A. Adebamowo2,4,5,6*
The vaginal microbiota is thought to play a role in modulating risk of high-risk human papillomavirus 
(hrHPV) infection. We examined the relationship between the vaginal microbiota and persistent 
hrHPV infection in HIV-negative and HIV-positive women. We used 16S-rRNA sequencing to 
characterize the vaginal microbiota of two serial samples taken six months apart from 211 Nigerian 
women (67%, 142/211 HIV-positive and 33%, 69/211 HIV-negative) and evaluated the association 
between the vaginal microbiota and persistent hrHPV infection using generalized estimating equation 
logistic regression models and linear discriminant analysis effect size (LEfSe) algorithm to identify 
phylotypic biomarkers of persistent hrHPV infection. The high diversity microbiota, Community State 
Type IV-B, was the most prevalent in both HIV-negative (38% at baseline, 30% at the follow-up visit) 
and HIV-positive (27% at baseline, 35% at the follow-up visit) women. The relationship between 
the vaginal microbiota and persistent hrHPV was modified by HIV status. In HIV-negative women, 
women with Lactobacillus dominant microbiota had lower odds (OR: 0.35, 95% CI 0.14–0.89, p = 0.03) 
of persistent hrHPV compared to women with Lactobacillus deficient microbiota. While among 
HIV-positive women, the odds of being persistently infected with hrHPV was higher in women with 
Lactobacillus dominant microbiota (OR: 1.25, 95% CI 0.73–2.14 p = 0.41). This difference in effect 
estimates by HIV was statistically significant (p = 0.02). A high diversity vaginal microbial community 
with paucity of Lactobacillus species was associated with persistent hrHPV infection in HIV-negative 
women but not in HIV-positive women.
Cervical cancer is the third commonest cancer among women globally, with 570,000 new cases and 311,400 
deaths estimated to have occurred globally in  20181. Persistent infection with one of 12 high risk Human Papil-
lomaviruses (hrHPV) is recognized as a necessary but insufficient cause of cervical intraepithelial neoplasia (CIN) 
and cervical  cancer2. HPV infections are very  common3. About 80% of sexually active women are infected with 
at least one HPV type at some point in their  lifetimes3. However, around 90% of infections are cleared within 
18 months, as a result of an incompletely understood host cell-mediated immune  response4. Persistence of HPV 
infection leads to the accumulation of mutations in the somatic cellular genome which increases the risk of CIN 
and cervical  cancer5. Interactions between host factors such as the microbiota and viral factors that facilitate 
persistence and carcinogenesis are not completely understood and remain an active area of research.
There is emerging evidence to suggest that the hosts’ vaginal microbiota play crucial roles in the pathogen-
esis of HPV  infections6,7. The defence mechanisms against colonization of the vagina by pathogenic organisms 
include the presence of lactic acid producing Lactobacillus  species8, an acidic  environment9,10 and antimicrobial 
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 peptides10,11. Disruptions in these defence mechanisms, as could occur with high diversity vaginal microbiota, 
may modulate risk of viral infections such as  HIV12 and  HPV13. High diversity vaginal microbial communities 
are associated with proinflammatory responses which may directly damage the cervical epithelial barrier, thereby 
facilitating HPV entry to basal keratinocytes and establishment of  infection4,14. The microbiota may also interact 
with cellular pathways in ways that are not yet clear, to lead to persistent, productive viral  infections14–17.
Most 16S rRNA sequencing studies of the vaginal microbiota and hrHPV infection to date have focused 
on prevalent hrHPV infection and vaginal microbiome  patterns6,13,16,18–22. Collectively, these studies showed 
increased risk of prevalent HPV infection in women with high diversity vaginal microbiota or with decreased 
relative abundance of Lactobacillus species13,16,19. Thus far, only one study has investigated the association between 
the vaginal microbiota and persistent  hrHPV21. In that study, vaginal samples collected at one baseline visit 
were used to characterize the vaginal microbiota, while hrHPV persistence was determined by testing two 
serial samples taken 12 months  apart21. Given that the vaginal microbiota is dynamic, cross-sectional studies of 
the vaginal microbiota that rely on vaginal sampling at a single time point are inadequate to fully characterize 
the relationship between the vaginal microbiota and persistent  hrHPV23. Therefore, longitudinal studies with 
repeated vaginal microbiota assessments are warranted. Earlier work by Brotman et al. to address this knowledge 
gap involved extensive sampling of the vaginal microbiota and repeated HPV testing. However, that study was 
limited by the lack of data on high risk  HPV24.
We previously reported an association between prevalent hrHPV and decreased relative abundance of Lac-
tobacillus  species18. In this study, we examine the relationship between the vaginal microbiota measured at two 
different time points and persistent hrHPV infection in a nested case control study of HIV-negative and HIV-
positive Nigerian women.
Results
Study population. From a prospective population—based cohort study of 1020 women, we selected 211 
women (94 cases of persistently any HPV infected and 117 controls of persistently HPV negative women) for 
inclusion in this nested case control study using a 1:1 match for HIV positive women and a 1:2 match for HIV 
negative women. Details of participant selection are provided in Fig. 1.
Table 1 shows the baseline characteristics of the study population stratified by HIV status. Mean (SD) age of 
participants at enrolment was 38 (8) years while mean age at sexual debut was 20 (3) years. Most participants 
had more than six years of formal education (88%, 186/211) and were premenopausal (84%, 175/211). More than 
half of the participants were married (58%, 122/211) and douche regularly (60%, 126/211). The median interval 
(IQR) between baseline and follow-up visit was 6 (6–8) months.
Of the 117 controls (women who were persistently negative for HPV), 39% (46/117) were HIV negative. 
Of the 94 cases (women who were persistently positive for any HPV), 24% (23/94) were HIV negative. Among 
women with persistent any HPV infection, 76% (71/94) had persistent hrHPV infections.
Among cases, the commonest hrHPV types detected were HPV 52 and HPV 35 at both baseline (27%, 
25/94 and 23%, 22/94 respectively) and follow up visits (31%, 29/94 and 19%, 18/94 respectively). Details of the 
frequency distribution of other high risk HPV types identified in women with persistent any HPV infection at 
baseline and follow up stratified by HIV status are shown in Table 2. In women with persistent hrHPV infection, 
type specific persistence (same hrHPV type present at baseline and follow up) was commoner (87%, 62/71) than 
group persistence (13%, 9/71). The commonest hrHPV types in type specific persistence were HPV 52 (31%, 
22/71) and HPV 35 (24%, 17/71). Further details of HPV prevalence, persistence and clearance of the parent 
cohort have been previously  published25,26.
There were 422 visits made by the 211 participants selected. Approximately, 84% (353/422) of vaginal micro-
biota samples taken at these visits were available for 16S rRNA sequence analysis which yielded 12, 967, 629 high 
quality reads. The mean (SD) number of reads per sample was 36, 021 (14, 375), with a mean (SD) read length 
of 427 (6) base pairs.
Vaginal microbiome composition in the study population. Hierarchical clustering analysis based 
on species composition and relative abundance identified five major clusters that showed similarities to previ-
ously described vaginal microbiome community state types (CST)23. Three of these CSTs were dominated by 
high proportions of Lactobacillus specie: L. crispatus in CST I, L. gasseri in CST II and L. iners in CST III (Fig. 2). 
CST I-B had moderately high proportions of Lactobacillus species, most commonly L. crispatus as well as low 
proportions of pathobionts such as Enterococcus and Streptococcus, which are not commonly seen in CST I. CST 
IV-B was characterized by greater taxonomic diversity with low proportions of Lactobacillus, pathobionts such 
as Escherichia, Enterococcus and Streptococcus as well as bacterial vaginosis associated taxa such as Gardnerella, 
Atopobium, Megasphaera, Sneathia and Prevotella.
Alpha diversity was significantly lower in CST I compared to CST II (p < 0.001), CST I-B (p < 0.001) and CST 
IV-B (p < 0.001). There were no significant differences in alpha diversity between CST I and CST III (p = 0.06) 
(Fig. 3). Lactobacillus species were present in all CSTs (Fig. 4). The median (IQR) relative abundance of Lacto-
bacillus species was 97% (90–98%) in CST I; 75% (50–93%) in CST II; 95% (87–98%) in CST III; 77% (57–95%) 
in CST I-B and 27% (11–42%) in CST IV-B.
In HIV negative women, the point prevalence of CST IV-B was 38% (26/69) at the baseline visit and 30% 
(21/69) at the follow up visit (Table 3). The difference in proportions (0.12; 95% CI − 0.06–0.30; p = 0.20) was 
not statistically significant. In HIV positive women, the point prevalence of CST IV-B was 27% (38/142) at the 
baseline visit and 35% (50/142) at the follow up visit. This CST distribution at the baseline and follow up visit was 
not statistically significant (difference in proportions = 0.06, 95% CI = − 0.10–0.14, p = 0.75). Of the Lactobacillus 
species dominant CSTs, CST III was the most prevalent at both baseline (15%, 10/69) and follow up (30%, 21/69) 
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visits in HIV negative women. In HIV positive women, the most prevalent Lactobacillus species dominant CST 
was CST III at the baseline visit (9%, 13/142) and CST II at the follow up visit (15%, 21/142) (Table 3).
Markov chain transition probabilities indicated substantial variability in inter-CST transitions over the two-
time points (baseline and follow-up visits) (Fig. 5). Patterns of transition probabilities were comparable among 
HIV positive and HIV negative women. In both HIV negative and HIV positive women, the highest inter-state 
transition probabilities were to the more diverse community (CST IV-B). While the highest self-transition 
Figure 1.  Participant flow chart and selection of participants in nested case control analysis.
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probability, the probability that a CST would be the same at both baseline and follow up, was observed for CST 
IV-B in both HIV negative and HIV positive women, indicating that CST IV-B was the most stable CST among 
women in this study.
In HIV negative women, transition probabilities from other CSTs to CST IV-B were 0.40 (CST I), 0.67 (CST 
II), 0.57 (CST III), and 0.33 (CST I-B). There were no transitions from a Lactobacillus dominant CST (CST I, 
CST II, CST III) to CST I-B, while CST II was the least connected CST. Transitions from CST IV-B were most 
Table 1.  Baseline characteristics of study population by HIV status. *Proportion of women who douche with 
water among women who regularly douche.
All participants n = 211 (%) HIV negative n = 69 (%) HIV positive n = 142 (%)
Mean, SD
Age, years 37.8 (8.25) 37.6 (9.03) 38.0 (7.86)
Age at sexual debut, years 19.7 (3.47) 20.7 (3.99) 19.2 (3.08)
Lifetime number of sexual partners 3.94 (3.84) 3.01 (2.02) 4.40 (4.40)
Number of partners in preceding year 1.04 (0.60) 1.01 (0.44) 1.05 (0.67)
n (%)
Socioeconomic status
Low 95 (45.0) 22 (31.9) 73 (51.4)
Middle 82 (38.9) 27 (39.1) 55 (38.7)
High 34 (16.1) 20 (29.0) 14 (9.86)
Education, years
 ≤ 6 25 (11.9) 8 (11.6) 17 (12.0)
7 – 12 58 (27.5) 10 (14.5) 48 (33.8)
 > 12 128 (60.7) 51 (73.9) 77 (54.2)
Marital status
Unmarried 89 (42.2) 20 (29.0) 69 (48.6)
Married 122 (57.8) 49 (71.0) 73 (51.4)
Menopause
No 175 (83.7) 55 (80.9) 120 (85.1)
Yes 34 (16.3) 13 (19.1) 21 (14.9)
Time since last menstrual period, days
 ≤ 15 78 (49.7) 23 (46.9) 55 (50.9)
 > 15 79 (50.3) 26 (53.1) 53 (49.1)
Douche regularly
No 83 (39.7) 32 (46.4) 51 (36.4)
Yes 126 (60.3) 37 (53.6) 89 (63.6)
Douche material*
Water 96 (76.2) 25 (67.6) 71 (79.8)
Contraceptive use
None 86 (40.8) 39 (56.5) 47 (33.1)
Condoms 95 (45.0) 18 (26.1) 77 (54.2)
Oral Contraceptive 22 (10.4) 7 (10.1) 15 (10.6)
Hormonal injections 16 (7.58) 5 (7.3) 11 (7.75)
Body mass index, kg/m2 (N, %)
Normal weight, 18.5–24.9 65 (32.3) 14 (21.2) 51 (37.8)
Overweight, 25.0–29.9 83 (41.3) 27 (10.9) 56 (41.5)
Obese, ≥ 30.0 53 (26.4) 25 (37.9) 28 (20.7)
Sexual activity within 24 h of sampling
Vaginal sex 22 (10.4) 11 (15.9) 11 (7.8)
Oral sex 3 (1.42) 2 (2.90) 1 (0.70)
Digital penetration 25 (11.9) 14 (20.3) 11 (7.8)
Persistent any HPV
No 117 (55.4) 46 (66.7) 71 (50.0)
Yes 94 (44.6) 23 (33.3) 71 (50.0)
Persistent hrHPV
Type-specific persistence 62 (29.4) 12 (17.4) 50 (35.2)
Group persistence 9 (4.3) 2 (2.9) 7 (4.9)
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commonly to CST III (transition probability = 0.55). In HIV positive women, transition probabilities from other 
CSTs to CST IV-B were 0.18 (CST I), 0.33 (CST II), 0.38 (CST III) and 0.33 (CST I-B). There were no transitions 
from CST II to CST I-B.
Association between demographic, lifestyle and clinical characteristics and the vaginal micro-
biome. We evaluated potential demographic and behavioural correlates for a Lactobacillus species dominant 
microbiota and a Lactobacillus crispatus dominant microbiota, treating the vaginal microbiota as a time varying 
response variable with measurements at two time points – baseline and follow up visits (Table 4). In univariate 
analyses, being HIV-positive was significantly associated with reduced odds of having a Lactobacillus species 
dominant microbiome (OR: 0.53, 95% CI 0.34–0.84, p = 0.007) or a L.crispatus dominant microbiome (OR: 0.33, 
95% CI 0.15–0.72, p = 0.006). Adjustments for age in multivariable models did not significantly change this 
relationship. Other than HIV status, there were no other associations between demographic, lifestyle, or clinical 
characteristics and the vaginal microbiota.
Association between persistent hrHPV infection and vaginal microbiota. A priori, we consid-
ered the possibility of HIV modifying the relationship between the vaginal microbiota and persistent hrHPV 
based on results from previous studies and biological  plausibility18, 27. In effect modification analysis, the odds 
ratio of having persistent hrHPV for women with a Lactobacillus dominant microbiota (> 70%) versus a Lac-
tobacillus depleted microbiota was multiplied by a factor of 3.39 (95% CI 1.18–9.70, p = 0.02) for HIV-positive 
women as compared to HIV-negative women. Therefore, we present effect estimates by HIV strata.
Among HIV negative women, the odds of persistent hrHPV infection were significantly lower in women 
whose microbiota were dominated by Lactobacillus species (OR: 0.35, 95% CI: 0.14–0.89, p = 0.03) than women 
with Lactobacillus depleted microbiota. In HIV positive women, there was no significant association between 
persistent hrHPV infection and the vaginal microbiota in the Lactobacillus dominant model (OR: 1.25, 95% CI: 
0.73–2.14, p = 0.41) (Table 5). There were also no significant associations between the vaginal microbiota and 
persistent hrHPV in the other models (L.crispatus dominant [> 70%] model and Community State Assignment 
model) considered for both HIV-negative and HIV-positive women.
In sensitivity analyses varying cut points to dichotomize relative abundance of Lactobacillus species, with 
values ranging from 50 to 80% in increments of 5%, the association between Lactobacillus dominated microbiota 
and persistent hrHPV in HIV negative women was insensitive to cut off points between 50 and 80% indicating 
that results were robust within this range of cut points (Supplementary Table 1). Analysis of characteristics of 
Table 2.  Distribution of hrHPV types in 94 women with persistence of any HPV.
HPV type Total n = 94 (%) HIV negative n = 23 (%) HIV positive n = 71 (%)
Distribution of hrHPV types at baseline visit
16 6 (6.4) 0 (0.0) 6 (8.4)
18 9 (9.6) 2 (8.7) 7 (9.9)
31 9 (9.6) 2 (8.7) 7 (9.8)
33 9 (9.6) 2 (8.7) 7 (8.7)
35 22 (23.4) 3 (13.0) 19 (26.8)
39 3 (3.2) 0 (0.0) 3 (4.2)
45 4 (4.3) 1 (4.4) 3 (4.2)
51 7 (7.4) 1 (4.4) 6 (8.4)
52 25 (26.6) 6 (26.1) 19 (26.8)
56 5 (5.3) 2 (8.7) 3 (4.2)
58 5 (5.3) 2 (8.7) 3 (4.2)
59 5 (5.3) 0 (0.0) 5 (7.4)
Distribution of hrHPV types at follow up visit
16 8 (8.5) 0 (0.0) 8 (11.3)
18 11 (11.7) 1 (4.4) 10 (14.1)
31 13 (13.8) 2 (8.7) 11 (15.5)
33 5 (5.3) 1 (4.4) 4 (5.6)
35 18 (19.2) 3 (13.0) 15 (21.1)
39 4 (4.3) 1 (4.4) 3 (4.2)
45 4 (4.3) 1 (4.4) 3 (4.2)
51 7 (7.5) 0 (0.0) 7 (9.9)
52 29 (30.9) 7 (30.4) 22 (31.0)
56 2 (2.1) 0 (0.0) 2 (2.8)
58 5 (5.3) 2 (8.7) 3 (4.2)
59 1 (1.1) 0 (0.0) 1 (1.4)
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participants missing microbiome data indicated that missingness at baseline was associated with socioeconomic 
status; while missingness at follow up was associated with HIV status (Supplementary Table 2). These variables 
(socioeconomic status, study visit and HIV status) were used as auxiliary variables during multiple imputation 
for sensitivity analysis. Effect estimates from the imputed data were similar to effect estimates obtained from 
complete case analysis (Supplementary Table 3).
Figure 2.  Heatmap of the 40 most abundant bacterial taxa in 211 Nigerian women. Hierarchical clustering 
identified five major clusters. Three of these clusters were dominated by one Lactobacillus species: L.crispatus 
(CST I), L.gasseri (CST II) and L.iners (CST III). CST I-B and CST IV-B were more diverse with CST I-B having 
modest proportions of L.crispatus. Ward linkage clustering was used to cluster samples based on their Jensen-
Shannon distance calculated in the Vegan package in  R66.
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We used LEfSe modelling to identify specific bacterial taxa that may be differentially abundant in HIV nega-
tive women with and without persistent hrHPV; and HIV positive women with and without persistent hrHPV. 
We included HIV positive women in LEfSe analysis as the broad categories in the regression models may mask 
differences in non-dominant bacterial taxa. We found that in HIV-negative women, women with persistent 
hrHPV infection had significant over-representation of Leptotrichia species in their vaginal microbiota compared 
to HIV-negative women without persistent hrHPV infection (Fig. 6) Conversely, there was significant overrep-
resentation of Veillonella species in HIV-negative women who were persistently hrHPV negative compared to 
HIV negative women with persistent hrHPV infection (Fig. 6) . In HIV-positive women, we did not identify any 
discriminative features between the vaginal microbiota of women with persistent hrHPV infection and women 
who were persistently HPV negative.
Discussion
In this nested case control study of the vaginal microbiota and persistent hrHPV infection in HIV-negative 
and HIV-positive women, we found that a high relative abundance of Lactobacillus species was associated with 
reduced odds of persistent hrHPV infection in HIV-negative women but not in HIV-positive women. These 
results extend findings from our previous study, in which we showed a significant association between a low 
relative abundance of Lactobacillus species and increased odds of prevalent hrHPV, a more proximal causal 
intermediate in the relationship between hrHPV and cervical  cancer18. Consistent with our previous report on 
prevalent hrHPV and other studies, we also identified Leptotrichia species to be over-represented in HIV-negative 
women with persistent  hrHPV18,21.
Figure 3.  Shannon diversity indices as a measure of alpha diversity by community state types. Compared to 
CST I, alpha diversity is significantly higher in CST II, CST I-B and CST IV-B.
Figure 4.  Relative abundance of Lactobacillus species by Community State Assignments. Lactobacillus species 
were present in all communities. CST I-B had modest proportions of L.crispatus as well as other Lactobacillus 
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While recent longitudinal studies with repeated vaginal microbiota assessments that use next generation 
sequencing techniques have shown an association between higher vaginal microbial diversity and prevalent 
hrHPV or persistent any HPV, our study is the first to show this for persistent  hrHPV19,24. In one study conducted 
among Italian women, Di Paola et. al. provide evidence to show that a high diversity vaginal microbiota, CST IV, 
at baseline was predictive of future odds of persistent hrHPV, despite not accounting for the temporal dynamics of 
the vaginal  microbiota21. Several other cross-sectional studies have showed that decreased relative abundance of 
Lactobacillus species is associated with precancerous cervical lesions and cervical  cancer28–30. Collectively, these 
results suggest that the vaginal microbiome may play a role in cervical cancer pathogenesis.
It is plausible that the vaginal microbiome modulates risk of HPV  acquisition31, although there is limited 
mechanistic evidence for this relationship. It is also possible, though less probable, that the presence of HPV inter-
acts with the host immune system through complex mechanisms that lead to the presence of immunosuppressive 
Table 3.  CST characterization in the study population by HIV and HPV status in women persistently negative 
for HPV (HPV–), persistently positive for hrHPV (hrHPV + +) and persistently positive for non hrHPV (non 
hrHPV + +). N All participants included in analysis. HPV−− Negative for HPV at both baseline and follow 
up visits. hrHPV++ Positive for hrHPV at both baseline and follow up visits. Non hrHPV++ Persistently 
positive for non hrHPV at baseline and follow up visits. This group includes women positive for low risk HPV 
at baseline and positive for low risk HPV at follow up; positive for low risk HPV at baseline and positive for 
hrHPV at follow up; positive for hrHPV at baseline and positive for low risk HPV at follow-up.
Vaginal community at baseline
HIV negative women HIV positive women
N = 69 (%)
HPV−−






(%) N = 142 (%)
HPV−−







CST I 6 (9) 2 (4) 1 (7) 3 (33) 11 (8) 4 (6) 6 (11) 1 (7)
CST II 7 (10) 5 (11) 0 (0) 2 (22) 3 (2) 1 (1) 2 (4) 0 (0)
CST III 10 (15) 7 (15) 2 (14) 1 (11) 13 (9) 7 (10) 5 (9) 1 (7)
CST I-B 4 (6) 4 (9) 0 (0) 0 (0) 37 (26) 19 (27) 16 (28) 2 (14)
CST IV-B 26 (38) 17 (37) 9 (64) 0 (0) 38 (27) 17 (24) 17 (30) 4 (29)
Missing CST 16 (23) 11 (24) 2 (14) 3 (33) 40 (28) 23 (32) 11 (19) 6 (43)
Vaginal community at follow-up
HIV negative women HIV positive women
N = 69 (%)
HPV−−

















CST I 11 (16) 7 (15) 1 (7) 3 (33) 20 (14) 10 (14) 9 (16) 1 (7)
CST II 2 (3) 1 (2) 1 (7) 0 (0) 21 (15) 7 (10) 8 (14) 6 (43)
CST III 21 (30) 15 (33) 5 (36) 1 (11) 8 (6) 4 (6) 4 (7) 0 (0)
CST I-B 2 (3) 2 (4) 0 (0) 0 (0) 42 (32) 25 (35) 16 (28) 1 (7)
CST IV-B 21 (30) 13 (28) 5 (36) 3 (33) 50 (35) 25 (35) 20 (35) 5 (36)
Missing CST 12 (17) 8 (17) 2 (14) 2 (22) 1 (0) 0 (0) 0 (0) 1 (7)
Figure 5.  Markov chain transition probabilities over two time periods, approximately six months apart by 
HIV status. Arrow weights are proportional to the maximum likelihood estimate of the transition probability 
between CSTs at the baseline and follow up visits. Node sizes scale with the number of women in each CST. 
Numeric transition probabilities are shown on arrows for transition probabilities > 0.30. Markov chain schematic 
transitions were modelled using the markovchain package in  R67.
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cytokines that favour different vaginal  communities17,32,33. Alternatively, sexual activity, a common cofactor for 
both vaginal microbiota and HPV infection may explain the associations observed.
Consistent with previous studies on the temporal dynamics of the vaginal microbiota, we found that CST IV-B 
was the most stable CST and when transitions did occur, they were most commonly to the L.iners dominated CST 
 III23. These findings of the stability of CST IV-B may be considered to be qualitatively similar to a longitudinal 
study among 80 African women which showed that high diversity associated bacteria such as Prevotella bivia 
and Gadnerella vaginalis were consistently present in 91% and 58% of healthy women with a Nugent score of 
0–3 respectively, while L. crispatus was consistently present in only 47%34. These findings may reflect a lack of 
optimal protection against the growth of strict anaerobes by L. iners or the ability of L.iners to thrive in a range 
Table 4.  Association between potential risk factors and vaginal microbiome. *Relative abundance of 
Lactobacillus species > 70%. **Relative abundance of L. crispatus > 70%. † Frequency of exposure at the two 
visits combined. The outcomes and some variables (oral contraceptive use, condom use, total sex partners in 
1 year, total sex partners in lifetime, sex within 24 h, BMI, douche regularly, time since last menstrual period, 
menopausal state) were modelled as time varying covariates. Correlation within person measurements were 
accounted for in GEE models. Given the variability between participants that clustered in CST groups, we used 
a marker of community functionality—hence analysis by relative abundance of Lactobacillus. 70% is used at 
cut off because of the distribution of the relative abundance of Lactobacillus in the different CST groups. ‡ 59 
participants were missing vaginal microbiota at baseline, and 13 participants were missing vaginal microbiota 
at follow up.
Characteristic
Total‡ Lactobacillus dominant microbiota* L. crispatus dominant microbiota**
n† n† (%) OR (95% CI) p value n† (%) OR (95% CI) p value
Age, years – – 1.00 (0.97–1.03) 0.92 – 1.01 (0.97–1.06) 0.56
Socioeconomic status
Low 149 75 (50) 1.00 10 (7) 1.00
Middle 145 70 (48) 0.92 (0.57–1.48) 0.73 10 (7) 1.03 (0.42–2.50) 0.95
High 59 29 (39 0.95 (0.52–1.74) 0.88 5 (8) 1.29 (0.43–3.81) 0.65
Education, years
 ≤ 6 39 15 (38) 1.00 2 (5)
7–12 100 47 (47) 1.42 (0.68–2.95) 0.35 3 (3) 0.57 (0.09–3.64) 0.55
 > 12 214 112 (52) 1.76 (0.89–3.46) 0.10 20 (9) 1.91 (0.42–8.71) 0.41
Menopausal
No 294 141 (48) 1.00 17 (5) 1.00
Yes 48 26 (54)) 1.28 (0.65–2.53) 0.47 5 (10) 1.89 (0.68–5.23) 0.22
Time since last menstrual period, days
 ≤ 15 119 53 (45) 1.00 6 (5) 1.00
 > 15 125 58 (46) 1.08 (0.64–1.83) 0.78 8 (6) 1.29 (0.43–3.87) 0.65
Douche regularly
No 141 64 (45) 1.00 10 (7) 1.00
Yes 156 79 (51) 1.23 (0.78–1.96) 0.37 10 (6) 0.90 (0.36–2.21) 0.81
Body Mass Index, kg/m2
Normal weight, 18.5–24.9 110 52 (47) 1.00 5 (5) 1.00
Overweight,
25.0–29.9 144 75 (52) 1.21 (0.73–2.00) 0.45 10 (7) 1.57 (0.54–4.59) 0.41
Obese, ≥ 30.0 86 39 (45) 0.93 (0.51–1.67) 0.80 8 (9) 2.15 (0.70–6.64) 0.18
HIV status
Negative 110 66 (60) 1.00 14 (13) 1.00
Positive 243 108 (44) 0.53 (0.34–0.84) 0.007 11 (5) 0.33 (0.15–0.72) 0.006
Sex within 24 h
No 305 150 (49) 1.00 23 (8)) 1.00
Yes 46 23 (50) 1.08 (0.61–1.91) 0.80 1 (2) 0.69 (0.20–2.40) 0.56
Total sex partners in lifetime – – 0.98 (0.92–1.04) 0.45 – 0.97 (0.89–1.07) 0.61
Total sex partners in 1 year – – 1.04 (0.71–1.53) 0.83 – 0.71 (0.34–1.51) 0.38
Condom use
No 192 100 (52) 1.00 16 (8) 1.00
Yes 74 74 (46) 0.78 (0.51–1.20) 0.26 9 (6) 0.65 (0.29–1.48) 0.31
Oral contraceptive use
No 315 156 (50) 1.00 24 (8) 1.00
Yes 38 18 (47) 0.92 (0.44–1.92) 0.82 1 (3) 0.33 (0.04–2.55) 0.29
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of metabolic stress related conditions that other Lactobacillus species cannot survive  in35. Future studies on the 
functional metabolomics profile associated with L. iners may help to understand the role of this specie in the 
maintenance and potential restoration of a healthy vaginal microbiota.
We found that HIV-positive women were less likely to have a high relative abundance of Lactobacillus species 
or L. crispatus compared to HIV-negative women. Microbial diversity has been reported to be an important risk 
factor for HIV acquisition and viral  shedding20,36,37. Recent reports, in which HIV susceptible CD4 + cells are 
increased in the genital tract in women with high diversity microbial communities, provide further mechanistic 
evidence for the link between increased risk of HIV acquisition and viral  shedding15,16. In addition, it is possible 
that the lower relative abundance of Lactobacillus species among HIV positive women in our study was due to 
immunosuppression resulting in subsequent colonization of genital tract by diverse bacteria.
Similar to previous studies, we did not find any significant association between vaginal douching and the 
vaginal  microbiota20,34,38,39. The influence of hygienic practices such as vaginal douching on the microbiota may 
be mediated by factors such as the type of materials used for douching and timing in the menstrual  cycle40,41. In 
a meta-analysis of intra-vaginal practices and bacterial vaginosis, which included 13 prospective studies in Sub 
Saharan Africa, vaginal douching with soap, but not other materials, was associated with bacterial  vaginosis41. 
In our study population, majority of women who reported douching regularly, used water to douche, providing 
some explanation for our findings.
In this analysis, we did not find any association between lifetime number of sexual partners, number of 
partners in past year, recent sexual activity and the vaginal microbiota. Previous studies have reported reduced 
Lactobacillus species in women with recent sexual  activity23,34. Our inability to detect these relationships may be 
due to the small sample size of women who reported recent sexual activity in our study.
Among HIV negative women, results from LEfSe analysis indicated that while Leptotrichia species was dif-
ferentially more abundant in persistent hrHPV infected women, Veillonella species was differentially more abun-
dant in hrHPV negative women. The association between Letptotrichia species and hrHPV infection has been 
reported in previous  studies18,21. Less frequently reported is the observation of a higher abundance of Veillonella 
Table 5.  Association between persistent hrHPV infection and vaginal microbiota. *Each model is adjusted for 
age.
Persistent hrHPV
HIV negative HIV positive
OR (95% CI) p OR (95% CI) p
Model 1*
Lactobacillus dominant microbiota
 < 70% 1.00 1.00
 ≥ 70% 0.35 (0.14–0.89) 0.03 1.25 (0.73–2.14) 0.41
Model 2*
L.crispatus dominant microbiota
 < 70% 1.00 1.00
 ≥ 70% 0.22 (0.03–1.43) 0.11 1.20 (0.82–1.76) 0.34
Model 3*
Community State Assignment
CST IV-B 1.00 1.00
CST I-B – 0.95 (0.50–1.82) 0.88
CST III 0.67 (0.28–1.61) 0.38 1.03 (0.39–2.70) 0.95
CST II 0.28 (0.04–2.02) 0.21 1.00 (0.40–2.55) 0.99
CST I 0.29 (0.06–1.46) 0.13 1.30 (0.40–2.54) 0.47
Figure 6.  Identified phylotype biomarkers of persistent hrHPV infection among HIV negative women. The 
phylotype biomarkers are identified as being significantly abundant at alpha value < 0.05. The analysis was run 
and visualized with the LEfSe program using the Galaxy  interface68. The Linear Discriminant Analysis (LDA) 
score is indicated at the bottom. The greater the LDA score, the more significant the phylotype biomarker is.
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in hrHPV negative women. Veillonella are anaerobic, gram negative cocci commonly found in the oral cavity, 
gut and vaginal tract that play diverse roles in different  niches42. The pathogenic role of Veillonella is uncertain 
and they are currently considered to be of low  virulence43,44. While Veillonella species have been associated with 
more diverse microbial communities, including the formation of biofilms leading to dental plaques in the oral 
cavity and serious infections such as  endocarditis45, they have also been found to be more abundant in HPV 
negative women compared to HPV positive  women13,46, as well as in the oral microbiota of HPV negative infants 
compared to the oral microbiota of HPV positive  infants46. Paradoxically, while they may be less common in HPV 
positive vaginal microbiota, they are increasingly more abundant in distal end points in the natural history of 
cervical cancer pathogenesis, such as in precancerous  lesions13, Bogert et al. observed that the cytokine response 
profile of Veillonella species within the gut microbiota is dependent on the combinations of the bacteria species 
 present47. These findings taken together with the paradoxical observations, may highlight the interplay between 
the integrated responses to multiple representative species within a microbial environment in influencing disease 
risk and warrant a deeper functional characterization of the vaginal microbiota.
The lack of association between Lactobacillus as a genus and hrHPV negative status in LEfSe analysis is 
noteworthy, given the strong associations between Lactobacillus species and hrHPV negative status that has 
been reported in previous studies. However, in this population, it must be noted that the commonest and the 
most stable microbial communities was the diverse CST IV-B community. This provides credence to current 
understanding that even in diverse communities, the important catabolic function, of lactic acid production, is 
conserved among communities despite differences in species composition.
Definitions of HPV persistence vary considerably across  studies48. The commonest definitions include HPV 
positivity measured at two or more time points with an interval of six or more  months48. At one extreme of this 
definition is the requirement for the same HPV genotype to be present at both time points (genotype-specific 
persistence), and the other extreme is the presence of any HPV at both time points (group persistence). Con-
ceivably, HPV genotype-specific persistence is better suited for identifying women at increased risk of cervical 
cancer and its precursor lesions, as group persistence could be the result of one HPV type clearing and another 
being acquired. However, results from a population-based cohort study in Denmark have shown that women 
with hrHPV group persistence have increased odds of high-grade precancerous lesions that are almost 200-
fold higher than observed in women persistently negative for  HPV49. Furthermore, in studies investigating the 
use of group persistence versus genotype specific persistence to inform referral practices, the use of genotype 
specific persistence did not improve risk stratification over the use of group persistence in women referred for 
colposcopy indicating that group persistence is a good proxy for measuring type-specific persistence and risk of 
high grade precancerous  lesions50,51.
While our study is the single largest nested case control study of persistent hrHPV and the vaginal microbiota 
among HIV-negative and HIV-positive women in Africa to date, it has some limitations. As with all case control 
studies, there is potential for selection bias when the selected cases and controls are systematically different from 
the target population especially when the selection criteria are associated with both the outcome and the expo-
sure of  interest52. In this study, the risk of selection bias is minimized for two reasons. First the parent cohort is 
a longitudinal population-based cohort; cases and controls selected from this cohort are representative of the 
source population with regards to exposure—outcome relationships. However, the prevalence of the exposure and 
outcome may vary substantially between the selected study population and the source population. Therefore, we 
limit our inferences to associations between exposure and outcome and make no inferences about the generaliz-
ability of the prevalence estimates of hrHPV or vaginal microbiota observed in this population. Secondly, while 
our selection criterion was associated with the outcome (all cases were selected), it was not associated with the 
exposure of interest. This reduces the risk of bias due to selection.
We included microbiome data from only two time points and did not perform qPCR to determine concentra-
tion. The human vaginal microbiota composition can be highly variable over short periods of time due to several 
factors, therefore sampling over shorter time intervals for extended periods are required. However, we did not 
find significant transitions of CST-IV to other CSTs, suggesting that additional sampling among women with 
CST IV may not have changed our results. There was some degree of missingness for vaginal microbiota data 
which could be a source of bias if differential. However, results from sensitivity analysis where missing vaginal 
microbiota was imputed based on visit (baseline or follow up), socioeconomic status and HIV status was not 
markedly different from the results based on complete non-missing data. We assessed HIV status at enrolment 
into the study but did not repeat HIV testing at follow up. It is possible that some women classified as HIV 
negative at the beginning of the study seroconverted during follow up, resulting in misclassification. We did not 
account for the CD4 + counts, viral loads, ART use or duration of infection in the HIV positive women included 
in this study and these may have affected our findings for HIV positive women.
In summary, we found that HIV negative women with a high relative abundance of Lactobacillus species in 
the vaginal microbiota had lower odds of persistent hrHPV compared to HIV negative women with lower rela-
tive abundance of Lactobacillus species. There was also an inverse relationship between the relative abundance 
of Lactobacillus species and HIV infection, such that women who were HIV-positive had lower odds of a Lacto-
bacillus specie dominant vaginal microbiota. Further work is required to understand the functional profile of the 
vaginal microbial communities and how this interacts with host factors to modulate risk of hrHPV persistence 
in the pathogenesis of cervical cancer.
Methods
Study population. We enrolled 1,020 women from our cervical cancer screening studies into a prospective 
study of host and viral factors associated with persistent hrHPV infection in Abuja, Nigeria between 2012 and 
 201353,54. We included non-pregnant women who were at least 18 years old, had engaged in vaginal sexual inter-
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course and had no previous history of hysterectomy or cervical cancer. Trained nurses collected information on 
sociodemographic characteristics, self-reported HIV status, lifestyle factors, sexual behaviour and reproductive 
history from all participants. Participants were scheduled for a follow-up visit six months after the baseline visit. 
At both baseline and follow-up visits, nurses performed gynaecological examinations and collected biological 
specimens.
For this analysis, we used a nested case control design restricted to 211 women selected as cases and controls. 
Details of patient selection are provided in Fig. 1. Of the 1020 women in the parent cohort, 23 HIV negative 
women and 71 HIV positive women were persistently positive for any HPV. All of these 94 women were selected 
as cases in this nested study. For each case we identified either one (for HIV positive cases) or two (for HIV nega-
tive cases) controls from the cohort, matched by age (± 5 years) and study enrolment date (± 5 days) resulting in 
117 controls in total. These 211 women provided data at two clinic visits resulting in 422 visits.
Sample collection and processing. We collected mid-vaginal swabs from all participants using the Elu-
tion Swab system (Copan, Italy) which was inserted in one ml Amies’ Transport media (Copan, Italy) and stored 
at − 80 °C till further processing. Whole genomic bacterial DNA was extracted from the swabs using the MoBio 
Powersoil kit, as previously  described18.
Bacterial 16S rRNA gene sequencing and analysis. A dual barcode system with fusion primers 338F 
and 806R was used to amplify the V3–V4 hypervariable regions of the 16S rRNA gene as previously  described55,56. 
Purified amplicons were sequenced on an Illumina Miseq instrument (Illumina, San Diego, CA) using a 300 bp 
paired end protocol at the Institute for Genome Sciences, University of Maryland School of Medicine. Raw reads 
were pre-processed to remove the first three and last three bases if their Phred score was lower than 3. Read ends 
were trimmed if the average Phred quality score of four consecutive bases was below 15 and only retained if their 
length was at least 75% of their original length after trimming. QIIME (v1.8.0)57 was used to perform quality 
control of the sequence reads. Fast Length Adjustment of Short reads (FLASH)58 was used to assemble paired 
reads, with an overlap of ~ 90 bp on average. De-multiplexing by binning sequences with the same barcode was 
performed in QIIME (v1.8.0). Chimera detection was done using de novo and referenced-based methods in 
UCHIME (v5.1) with the Greengenes database of 16S rRNA gene sequences (August 2013) as a  reference59,60. 
The processed 16S rRNA gene amplicon sequences were assigned to genera and species, using PECAN that uses 
fifth-order Markov Chain model for precise species-level assignments and a pre-compiled database that contains 
all known microbes in the vaginal microbiota. Raw, demultiplexed, sequence files are available at the NBCI 
Sequence Read Archive (https ://www.ncbi.nlm.nih.gov/sra) with accession code PRJNA668516. Hierarchical 
clustering analysis based on Jensen Shannon distances using ward linkage was used to cluster samples into Com-
munity State Types (CSTs) using the vegan package in  R23.
HPV detection. We extracted DNA from ectocervical cells and used the  SPF10LiPA25 system for HPV DNA 
 detection61. Briefly, we performed polymerase chain reaction on DNA isolates using biotin labeled  SPF10 prim-
ers which generated small amplicons of 65 bp. The amplified PCR products were tested using DNA Enzyme 
Immunoassay (DEIA), a probe hybridization assay containing a cocktail of conservative probes that allows the 
recognition of at least 65 HPV genotypes. The amplimers of the DEIA HPV DNA positive samples were subse-
quently analyzed by the reverse hybridization line probe assay,  LiPA25, Version 1 (Laboratory Biomedical Prod-
ucts, Rijswijk, The Netherlands) which can identify 25 HPV types, 12 of which are high-risk: 16, 18, 31, 33, 35, 
39, 45, 51, 52, 56, 58, and 59. In this analysis, we use group persistence as the definition of persistent hrHPV, that 
is, the presence of at least one hrHPV type at baseline and one hrHPV type at the follow up visit as opposed to 
type specific persistence, which is the presence of identical hrHPV types at the two visits.
Covariates. We collected information on potential confounders such as menopausal state, time since last 
menstrual period, douching practice, total number of sexual partners in past year, body mass index (BMI), vagi-
nal pH, sexual activity within 24 h of sampling, use of condoms and hormonal contraceptive use. Vaginal pH 
was assessed as an ordinal variable with three categories: < 4.5, 4.5–5.5 and > 5.5. These covariates were assessed 
at the baseline visit and updated at the follow up visit. They were included in the models as time varying expo-
sures. The vaginal microbiota was also modelled as a time varying exposure. In addition to CST based models, 
we conducted analysis based on the relative abundance of Lactobacillus (at the genus level) and L. crispatus. We 
specifically investigated L.crispatus at the species level because, of all the species of the Lactobacillus genus, com-
monly identified in the vaginal microbiota, communities with high relative abundance of L.crispatus have the 
lowest vaginal pH values, a marker for important vaginal defence  mechanisms20,33,62.
Statistical analysis. We compared the characteristics of participants at baseline by HIV status. We used 
generalized estimating equation (GEE) logistic regression models with robust variance estimation and the clus-
ter option, which accounts for repeated measures, to investigate the relationship between potential risk factors 
and the vaginal microbiota; and the association between the vaginal microbiota and persistent hrHPV infection. 
Variables considered for inclusion in multivariable regression models were selected using a two-step approach. 
First, sociodemographic characteristics and potential risk factors associated with persistent HPV infection at a 
nominal p < 0.10 in the parent cohort of this study were identified from previously published  results25. The vari-
ables identified from this step were BMI, marital status, education, socioeconomic status, age at sexual initiation, 
total lifetime sex partners, vaginal douching, vaginal pH and HIV status. Next, we examined potential risk fac-
tors and its association with vaginal microbiota in this cohort of participants. Variables that were significantly 
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associated with the vaginal microbiota at p < 0.10 were identified. Finally, variables that were associated with 
both persistent HPV infection and the vaginal microbiota were selected for inclusion in multivariable models.
In modelling the vaginal microbiota, we considered three approaches: dichotomising based on L. crispatus 
relative abundance (using a cut off of 70%), dichotomising based on all Lactobacillus species relative abundance 
(using a cut off of 70%) and using CST assignments. To select the cut-off point, we used the mean of the relative 
abundance of L. crispatus in CST I because L. crispatus is often considered a marker of a healthy  microbiome19,63. 
We investigated the sensitivity of results to various cut points by varying the cut points in increments of 5% from 
50 to 80%. The upper and lower bounds for these sensitivity analyses were selected to ensure that we reached a 
point where further dichotomization would become uninformative.
We used Markov chain models generated by inferring transition probabilities from our data to evaluate vaginal 
community dynamics over the two time periods, the baseline visit and the follow up visit.
We used Linear Discriminant Analysis (LDA) effect size (LEfSe) algorithm to identify bacterial taxa that were 
differentially present in women with persistent hrHPV  infections64.
Of the 422 clinical visits included in this study, results for 69 vaginal microbiota samples were missing. We 
performed univariate analysis for missingness at baseline and at the follow up visit to determine whether missing-
ness was associated with important covariates such as HIV status, persistent hrHPV, age, socioeconomic status, 
education, menopausal state, time since last menstrual period, douching practice, BMI, sex within the last 24 h 
prior to sample collection and total number of sexual partners in the past one year. Furthermore, to minimize 
the potential for selection bias, we imputed missing microbiota data using a data augmentation algorithm in 
a Markov Chain Monte Carlo (MCMC) procedure creating 10 datasets in 1000 iterations. We included three 
variables as auxiliary predictor variables (socioeconomic status, study visit and HIV status) identified from the 
univariate analysis of missingness. Next, we implemented GEE logistic regression models in the imputed dataset 
and compared results obtained from the imputed data with results obtained from complete case analysis.
Based on previous studies that have provided evidence of increased microbial diversity and a higher risk of 
persistent hrHPV infections among HIV positive women compared to HIV negative  women25,27,65, we considered 
the possibility of HIV modifying the relationship between the vaginal microbiota and persistent hrHPV infection, 
a priori. We tested for this statistically by fitting an interaction term in the GEE logistic regression model and 
comparing the fitted model to a model without the interaction term using likelihood ratio tests. The interaction 
term was statistically significant (p = 0.02). Therefore, we present results by HIV strata.
All analyses were conducted using Stata/SE 15 (StataCorp, College Station, Texas) and R version 3.4.0 (R 
Core Team, Vienna, Australia).
Ethics. All methods were carried out in accordance with relevant guidelines and regulations. We obtained 
ethical approval to conduct this study from the National Health Research Ethics Committee of Nigeria and 
the University of Maryland School of Medicine Institutional Review Board. All participants provided written 
informed consent prior to enrolment.
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